Author:
Cui Xiaoran,Li Ruibin,Zhou Wenli,Zhang Xiaohui,Wang Xiaoning,Zhang Jidong
Abstract
ObjectivesTo compare the safety and efficacy of completely zero-fluoroscopy radiofrequency ablation (RFA) with that of conventional RFA guided by three-dimensional mapping in Chinese children with paroxysmal supraventricular tachycardia (PSVT).MethodsThe study had a single-center observational design and included 46 children aged 6–14 years who underwent RFA for PSVT at the Second Hospital of Hebei Medical University between March 2019 and September 2021. The children were divided according to whether they underwent zero-fluoroscopy RFA (zero-fluoroscopy group, n = 26) or routine RFA under X-ray guidance (conventional group, n = 20). Three-dimensional mapping was used in both groups. Baseline characteristics, total procedure time, RFA time, volume and duration of X-ray exposure, target mapping time, the immediate RFA success rate, incidence of complications, and recurrence rate were compared between the two groups.ResultsThe children had a median age of 12 years (interquartile range 10, 13), 47.8% (22/46) were boys, and 52.2% (24/46) were girls. The mean body weight was 48.75 ± 15.26 kg. There was no significant between-group difference in the baseline data (P > 0.05). All children were followed up as outpatients at 1, 3, and 6 months postoperatively. The target mapping time was significantly longer in the zero-fluoroscopy group than in the conventional group (12.96 ± 2.24 min vs. 6.65 ± 2.56 min, P < 0.05); however, there was no significant between-group difference in the immediate success rate (100% vs. 100%), success rate at 6 months postoperatively (92.30% vs. 95.00%), complication rate (0% vs. 0.05%), recurrence rate (7.70% vs. 5.00%), RFA time (212.50 s vs. 214.00 s), or total procedure time (78.50 min vs. 74.00 min) (P > 0.05).ConclusionZero-fluoroscopy catheter ablation can completely avoid fluoroscopy exposure in children without affecting the safety and efficacy of RFA.
Subject
Cardiology and Cardiovascular Medicine
Reference37 articles.
1. Supraventricular tachycardia in infants, children and adolescents: diagnosis, and pharmacological and interventional therapy.;Paul;Paediatr Drugs.,2000
2. Supraventricular tachycardia in infants: epidemiology and clinical management.;Calabrò;Curr Pharm Des.,2008
3. Pediatric intra-cardiac electrophysiological study and radiofrequency catheter ablation of tachyarrhythmia——a national multicenter clinical study.;Li;Chin J Cardiac Arrhythm.,2014
4. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: developed in partnership with the pediatric and congenital electrophysiology society (PACES) and the heart rhythm society (HRS). Endorsed by the governing bodies of PACES, HRS, the American academy of pediatrics (AAP), the American heart association (AHA), and the association for European pediatric and congenital cardiology (AEPC).;Philip Saul;Heart Rhythm.,2016
5. Supraventricular tachycardia due to Wolff-Parkinson-White syndrome in children: early disappearance and late recurrence.;Perry;J Am Coll Cardiol.,1990
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献